Taichi Horino's research while affiliated with Kumamoto University and other places

Publications (7)

Article
Background Advanced lung cancer inflammation index (ALI) is reported to be a prognosticator in various cancer patients with chemotherapy. However, the clinical impact of the ALI on treatment strategies in metastatic colorectal cancer (mCRC) patients remains unclear.MethodsA total of 356 patients, who received first-line chemotherapy for mCRC betwee...
Article
Full-text available
Background Shanghai fever is a rare community-acquired enteric illness with sepsis caused by Pseudomonas aeruginosa . Cases of Shanghai fever in pediatric patients have been reported; however, to the best of our knowledge, there are no reports of adult cases. Case presentation A 65-year-old man visited the emergency department with sudden onset of...
Article
Full-text available
Background The advanced lung cancer inflammation index (ALI), which comprehensively evaluates the patient body composition and inflammation/nutritional status, is reportedly associated with the patient outcome in lung cancer. However, the clinical significance in colorectal cancer (CRC) patients after curative resection remains unclear. Methods A...
Article
Full-text available
Background: Port site recurrence has been observed after a variety of oncologic resection procedures. However, few have reported port site recurrence of esophageal cancer. Case presentation: A 51-year-old man underwent minimally invasive esophagectomy for pT3(AD)N3M0 adenocarcinoma of the esophagus. One year after surgery, he presented with a ra...
Article
Full-text available
Background: The recurrence of endoscopically resected intramucosal colorectal cancer (CRC) is quite rare, and data regarding metastasis in intramucosal tumors are still lacking. We herein report a case of presacral lymph node recurrence of intramucosal rectal cancer after curative endoscopic resection. Case presentation: A 53-year-old man underw...

Citations

... A new prognostic index, defined as the cancer-inflammation prognostic index (CIPI), based on CEA and NLR, was recently introduced as a promising novel prognostic marker for metastatic CRC patients treated with regorafenib [26,27]. To our knowledge, CIPI has never been utilized as a prognostic marker in non-metastatic CRC after curative resection. ...